EDSA vs FOXA · $64.2M cap vs P/E 14, rev $17.13B
Edesa Biotech Inc (EDSA) versus Fox Corp Class A (FOXA) — a side-by-side from cached financials, not a winner call.
Edesa Biotech Inc (EDSA) is a biotechnology company listed on US.
Fox Corp Class A (FOXA) is a entertainment company listed on US.
EDSA does not have a complete income-statement cache yet.
Latest reported FOXA revenue for 2026-06-30 was $17.13B. Net income was $1.73B. Revenue was up 5.1% from 2025-06-30 to 2026-06-30. FOXA currently screens at market cap $24.50B and trailing P/E 14.1.
EDSA currently screens at market cap $64.2M. FOXA currently screens at market cap $24.50B and trailing P/E 14.1.
Not investment advice. Open the EDSA and FOXA stock pages for the full models.
Not investment advice.